Explore the emerging market of direct-to-consumer blood biomarker tests for Alzheimer's disease, their regulatory context, limitations, and implications for healthcare, cognitive assessment, and insurance.

Analysis of Medicare data reveals increased home healthcare use among dementia patients from 2010-2019, with a decline post-2020 linked to staffing shortages. Highlights coverage gaps and utilization trends.